Use of antipsychotic medication in active drug users, patients receiving opioid substitution therapy (OST) and HCV patients

Conference Reports for NATAP

The Liver Meeting
Digital Experience
AASLD
November 13 - 16 - 2020


Use of antipsychotic medication in active drug users, patients receiving opioid substitution therapy (OST) and HCV patients

	AASLD 2020 Nov 11-16 virtual Reported by Jules Levin 1Alexander Apotheke, Hamburg, Germany; 2Gilead Sciences GmbH, Germany; 3Charite -UniversitätsmedizinBerlin, Department of Hepatology and Gastroenterology, Berlin, Germany